PHIPA, PIPEDA, and Pharmacy AI: What Canadian Pharmacy Owners Need to Know

When a pharmacy adopts an AI automation system, patient prescription data flows through that system. In Canada, that flow is regulated — and the regulations are specific about where data can go, who can access it, and what documentation must exist.

Most pharmacy owners are familiar with PHIPA and PIPEDA in the context of their own operations. Fewer have interrogated how these laws apply to the software vendors they use. This guide covers what you need to know before bringing any AI automation tool into your pharmacy.

What PHIPA covers

The Personal Health Information Protection Act (PHIPA) is Ontario’s health privacy legislation. It governs how “health information custodians” — which includes pharmacists and pharmacies — collect, use, and disclose personal health information (PHI).

For pharmacy automation specifically, PHIPA is relevant in two key ways:

Data handling by agents. When a pharmacy uses a software vendor that handles prescription data on its behalf, that vendor is acting as an “agent” under PHIPA. The pharmacy remains accountable for how that agent handles the data. If a vendor stores prescription data outside of Canada or shares it with subprocessors that the pharmacy has not reviewed, the pharmacy may be in breach — even if the pharmacy owner did not know it was happening.

Consent and purpose limitation. PHI collected for the purpose of dispensing a prescription cannot be used for other purposes without additional consent. An AI system that uses prescription data to train its models — without explicit consent from your patients — may violate PHIPA’s purpose limitation requirements.

Audit trail requirements. PHIPA requires that health information custodians maintain records of who has accessed PHI and for what purpose. Any automation system handling prescription data should generate and expose audit logs that satisfy this requirement.

What PIPEDA adds

The Personal Information Protection and Electronic Documents Act (PIPEDA) is the federal privacy law that applies to the commercial activities of private-sector organizations. For pharmacies outside Ontario (or in provinces without substantially similar provincial legislation), PIPEDA is the primary applicable law.

For pharmacy AI vendors, PIPEDA adds:

Consent for collection and use. PIPEDA requires that individuals consent to the collection and use of their personal information. For prescription data used in an automation pipeline, this consent typically flows from the existing patient-pharmacy relationship — but vendors who use that data beyond the dispensing purpose need to account for this separately.

Accountability and transparency. PIPEDA requires organizations to be accountable for the personal information under their control and to be transparent about their information practices. Ask vendors for their privacy policy, their subprocessor list, and their data retention policy.

Breach notification. Under PIPEDA, organizations must notify affected individuals and report to the Privacy Commissioner of Canada when a privacy breach occurs that creates a “real risk of significant harm.” Ask your vendor what their breach notification process is and how quickly they would notify you.

Three questions to ask any pharmacy AI vendor

1. Where is patient data stored, and does any of it leave Canada?

This is the single most important question. PHIPA and PIPEDA do not categorically prohibit data from leaving Canada, but storing PHI in the United States subjects it to the US Patriot Act and CLOUD Act, which can compel US companies to disclose data to US government agencies without notifying the data subject or the Canadian pharmacy.

The standard for Canadian pharmacies is Canadian data residency: patient data stored at rest in Canadian data centres, with data in transit encrypted and not routed through US infrastructure. Ask for this in writing in your contract and your DPA.

2. Who are your subprocessors, and what data do they access?

A subprocessor is any third party that your vendor uses to process data on their behalf. Cloud hosting providers, AI model providers, logging services, and monitoring tools can all be subprocessors. Each subprocessor that touches patient data is another link in the accountability chain.

Ask for a complete subprocessor list. Ask which subprocessors have access to identifiable PHI (as opposed to anonymized or aggregated data). Ask what DPAs exist between your vendor and their subprocessors.

3. How does your system use prescription data to train AI models?

This is increasingly important as AI systems become common in pharmacy workflows. If a vendor uses prescription data — even anonymized — to improve their models, that use should be disclosed and, depending on the nature of the data, may require patient consent.

Ask directly: does your system use any data from our pharmacy to train or fine-tune your AI models? If yes, how is the data anonymized, and what is the legal basis for this use?

Red flags

• No data processing agreement available. Any vendor that handles PHI on your behalf must be willing to sign a DPA. If they resist or say it is not necessary, that is a significant red flag.
• Vague answers on data residency. “We use AWS” is not an answer to where data is stored. AWS operates data centres in Canada and the US. Vague answers suggest the vendor does not know — or does not want you to know.
• No subprocessor list. A responsible vendor maintains and publishes a subprocessor list. If they cannot produce one, they do not have adequate control over their data supply chain.
• No audit log access for pharmacies. If your vendor cannot show you who accessed your patient data and when, you cannot satisfy PHIPA’s audit requirements.

What compliant pharmacy automation looks like

A PHIPA and PIPEDA compliant pharmacy automation system:

• Stores all patient data in Canadian data centres, with this commitment documented in the contract and DPA
• Publishes a subprocessor list and maintains DPAs with each subprocessor that touches PHI
• Does not use patient data for model training without explicit disclosure and appropriate consent
• Provides pharmacy operators with access to audit logs covering data access and usage
• Has a documented breach notification process with defined timelines
• Offers a Data Processing Agreement as a standard part of the contract — not as a special request

AutoRx is built to meet these requirements. Canadian data residency, PHIPA and PIPEDA alignment, subprocessor documentation, and DPAs are standard — not upsells. Review our Trust Center, Security, and Subprocessors pages for the documentation.

Contact us if you have compliance questions before evaluating.